Printer Friendly

Traditional test poor predictor of heart disease.

Contrary to conventional thinking, a new study suggests that emergency room patients who are relieved of chest pain after taking a nitroglycerine pill are no more likely to be diagnosed with heart disease than those who are not.

The research team--comprised of emergency physicians and cardiologists from the University of California, Davis Medical Center in Sacramento--tested 664 patients, almost evenly split between men (48 percent) and women (52 percent), who arrived at an emergency department complaining of chest pain. Using an 11-point pain intensity scale, researchers measured patients' perceptions of chest pain after they were given nitroglycerin and compared this to their diagnosis of heart disease. No relationship was found.

Nitroglycerin works to relieve chest pain caused by coronary artery disease by relaxing the blood vessels to the heart, thus increasing blood flow and oxygen supply to the heart. For patients without heart disease whose chest pain was reduced by nitroglycerin, researchers suspect the drug may have relieved muscle spasms in the esophagus.
COPYRIGHT 2005 Benjamin Franklin Literary & Medical Society, Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2005 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Medical Update
Date:May 1, 2005
Words:163
Previous Article:New technique restores leg circulation.
Next Article:Keep on the sunny side.
Topics:


Related Articles
Leptin augers heart attack, diabetes?
Telltale charts: is anticipating heart disease as easy as 1, 2, 3, 4?
Friendship: good for the heart.
Simple way to predict heart disease and strokes.
Questions remain about safety of hormone therapy.
Poor women are at elevated risk for HPV infection, but few variables predict risk among those in poverty.
Advanced technology uncovers hidden cardiovascular risks.

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters